A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients

AIDS

Volumn 11, Issue 2, 1997, Pages 177-184

  Raffi, François ^a,h   Aboulker, Jean Pierre ^b   Michelet, Christian ^c   Reliquet, Véronique ^a   Pelloux, Hervé ^d   Huart, Alain ^a   Poizot Martin, Isabelle ^e   Morlat, Philippe ^f   Dupas, Benoît ^a   Mussini, Jean Marie ^a   Leport, Catherine ^g  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e University Hospital of Marseille   (France)

^f University Hospital   (France)

^g BICHAT HOSPITAL   (France)

^h HÔTEL DIEU   (France)

Author keywords

AIDS; CT brain scan; Empirical therapy; Logistical model; Prophylaxis; Toxoplasma serology; Toxoplasmic encephalitis

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; ENCEPHALITIS; FEMALE; FEVER; FRANCE; HEADACHE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; STATISTICAL MODEL; TOXOPLASMOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DIAGNOSIS, DIFFERENTIAL; ENCEPHALITIS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; TOXOPLASMOSIS;

EID: 8044243590     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199702000-00007     Document Type: Article

References (40)

1. Levy RM, Bredesen DE: Central nervous system dysfunction in acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1988, 1:41-64.
2. Luft BJ, Remington JS: Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992, 15:211-222.
3. Renold C, Sugar A, Chave JP, et al.: Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine 1992, 71:224-239.
4. Clumeck N, Sonnet J, Taelman H, et al.: Acquired immunodeficiency syndrome in African AIDS patients. N Engl J Med 1984, 10:492-497.
5. Leport C, Raffi F, Matheron S, et al.: Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med 1988, 84:94-100.
6. Cohn JA, McKeeking A, Cohen W, Jacobs J, Holzman RS: Evaluation of the policy of empiric treatment of suspected toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 1989, 86:521-527.
7. Porter SB, Sande MA: Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992, 237:1643-1648.
8. Haverkos HW: Assessment of therapy for toxoplasma encephalitis. Am J Med 1987, 82:907-914.
9. Luft BJ, Hafner R, Korzun AH, et al.: Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993, 329:995-1000.
10. Derouin F, Beauvais B, Larivière M: Serologic study of the prevalence of toxoplasmosis in 167 patients with acquired immunodeficiency syndrome (AIDS) or chronic lymphadenopathy syndrome (LAS). Biomed Pharmacother 1988, 40:231-232.
11. Ragnaud JM, Morlat P, Dupon M, Lacoste D, Pellegrin JL, Chene G: Toxoplasmose cérébrale au cours du SIDA. 73 observations. Presse Med 1993, 22:903-908.
12. Remington JS, Desmont G: Toxoplasmosis. In Infectious Diseases of the Fetus and Newborn Infant. Edited by Remington JS, Klein JO. Philadelphia: WB Saunders Company; 1990:84-179.
13. Danneman BR, McCutchan JA, Israelski DM, et al.: Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfonamides. Ann Intern Med 1992, 116:33-43.
14. Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW: Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 1986, 19:224-238.
15. Levy RM, Rosenbloom S, Perrett LV: Neuroradiologic findings in AIDS: a review of 200 cases. Am J Roentgenol 1986, 7:833-839.
16. Ciricillo SF, Rosenblum ML: Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 1990, 73:720-724.
17. Dina TS: Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology 1991, 179:823-828.
18. Levy RM, Mills CM, Posin JP, Moore SG, Rosenblum ML, Bredesen DE: The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study. J Acquir Immune Defic Syndr 1990, 3:461-471.
19. Cordoliani YS, Derosier C, Pharaboz C, Jeanbourquin D, Schill H, Cosnard G: MRI of primary cerebral lymphoma in AIDS. Am J Roentgenol 1992, 159:841-847.
20. Von Einsiedel RW, Fife TD, Aksamit AJ, et al.: Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 1991, 240:391-406.
21. The American Academy of Neurology AIDS Task Force: Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS Task Force. Neurology 1991, 41:778-785.
22. Derouin F, Sarfati C, Beauvais B, Iliou MC, Dehen L, Lirivière M: Laboratory diagnosis of pulmonary toxoplasmosis in patients with acquired immunodeficiency syndrome. J Clin Microbiol 1989, 27:1661-1663.
23. Derouin F, Garin YJF: Isolement de Toxoplasma gondii par culture cellulaire chez les sujets infectés par le VIH. Presse Med 1992, 21:1853-1856.
24. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41: RR-17.
25. Dhiver C, Milandre C, Poizot-Martin I, Drogoul MP, Gastaut JL, Gastaut JA: 5-fluoro-uracil-clindamycin for treatment of cerebral toxoplasmosis [letter]. AIDS 1993, 7:141-144.
26. Kovacs JA, the NIAID-Clinical Center Intramural AIDS Program: Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. Lancet 1992, 340:637-638.
27. Canessa A, Del Bono V, De Leo P, Piersantelli N, Terragna A: Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients. Eur J Clin Microb Infect Dis 1992, 11:125-130.
28. Mathews C, Barba D, Fullerton SC: Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS 1995, 9:1241-1250.
29. Anonymous: Surveillance du SIDA en France. Situation au 30 Juin 1995. Réseau national de Santé publique. Bull Epidemiol Hebdom 1995, 32:141-147.
30. Levine AM, Sullivan-Halley J, Pike MC, et al.: Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival. Cancer 1991, 68:2466-2472.
31. Bourdillon F, Cavaignac L, Nadal JM, Pradier C, Bez G: Déficit immunitaire et survenue des principales infections opportunistes dans la pathologie VIH. In L'Hôpital dans la lutte contre le SIDA. Paris: Direction des Hôpitaux 1995:26-32.
32. Michelet C, Raffi F, Besnier JM, et al.: Cotrimoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, October 1993 [abstract 1071].
33. May T, Beuscart C, Leclercq P, et al.: Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled, clinical trial. J Acquir Immune Defic Syndr 1994, 7:457-462.
34. Carr A, Tindall B, Brew BJ, et al.: Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992, 117:106-111.
35. Contini C, Romani R, Magno S, Delia S: Diagnosis of Toxoplasma gondii infection in AIDS patients by a tissue-culture technique. Eur J Clin Microbiol Infect Dis 1995, 14:434-440.
36. Leport C, Reminton IS: Toxoplasmose au cours du SIDA. Presse Med 1992, 21:1165-1171.
37. Dupouy-Camet J, De Souza, Maslo C, et al.: Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol 1993, 31:1866-1869.
38. Khalifa KE, Roth A, Roth B, Arasteh KN, Janitshke K: Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol 1994, 32:2813-2819.
39. Leport C, Chêne G, Morlat P, et al.: Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. J Infect Dis 1996, 173:91-97.
40. Girard PM, Landman R, Gaudebout C , et al.: Dapsonepyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993, 328:1514-1520.